Stay updated on Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page
- Check2 days agoChange DetectedUpgrade to v3.0.2 adds a Study Status entry dated 2025-09-09 and a new date 2025-09-10, while removing the older 2025-08-29 date and v3.0.1 (and the Back to Top link).SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, as well as various study status updates and outcome measures. Notably, specific dates related to study statuses have been added, while some location-related terms have been removed.SummaryDifference92%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has updated its version from v2.16.11 to v2.16.12, and the date has changed from 2025-07-23 to 2025-08-14.SummaryDifference1.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
- Check45 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference4%
Stay in the know with updates to Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo with Canakinumab in NSCLC Clinical Trial page.